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Studies suggested that in human adults, linoleic acid (LA) inhibits the biosynthesis of n-3 long-chain polyunsaturated fatty acids
(LC-PUFA), but their effects in growing subjects are largely unknown. We used growing pigs as a model to investigate whether
high LA intake affects the conversion of n-3 LC-PUFA by determining fatty acid composition and mRNA levels of D5- and D6
desaturase and elongase 2 and -5 in liver and brain. In a 23 2 factorial arrangement, 32 gilts from eight litters were assigned to
one of the four dietary treatments, varying in LA and a-linolenic acid (ALA) intakes. Low ALA and LA intakes were 0.15 and 1.31,
and high ALA and LA intakes were 1.48 and 2.65 g/kg BW0.75 per day, respectively. LA intake increased arachidonic acid (ARA) in
liver. ALA intake increased eicosapentaenoic acid (EPA) concentrations, but decreased docosahexaenoic acid (DHA) (all P, 0.01)
in liver. Competition between the n-3 and n-6 LC-PUFA biosynthetic pathways was evidenced by reductions of ARA (.40%) at
high ALA intakes. Concentration of EPA (.35%) and DHA (.20%) was decreased by high LA intake (all P, 0.001). Liver mRNA
levels of D5- and D6 desaturase were increased by LA, and that of elongase 2 by both ALA and LA intakes. In contrast, brain
DHA was virtually unaffected by dietary LA and ALA. Generally, dietary LA inhibited the biosynthesis of n-3 LC-PUFA in liver. ALA
strongly affects the conversion of both hepatic n-3 and n-6 LC-PUFA. DHA levels in brain were irresponsive to these diets. Apart
from D6 desaturase, elongase 2 may be a rate-limiting enzyme in the formation of DHA.
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Implications
Docosahexaenoic acid (DHA; c22:6 n-3) and eicosapentaenoic
acid (EPA; c22:5 n-3) are important n-3 fatty acids to improve
human health. DHA is important in brain for cognitive develop-
ment. This study has been carried out with growing pigs as
model for humans. The n-3 fatty acid such as a-linolenic acid
(ALA; c18:3 n-3) is a precursor for DHA and EPA via enzymatic
steps. EPA can be increased in the liver by dietary ALA. Feeding
of linoleic acid (LA; c18:2 n-6), a precursor for a competitive
pathway, inhibits the synthesis of EPA. The potential for
increasing brain DHA via an increase in dietary ALA is limited.
Introduction
Arachidonic acid (ARA; c20:4 n-6), eicosapentaenoic acid
(EPA; c20:5 n-3) and docosahexaenoic acid (DHA; c22:6 n-3)
are long-chain polyunsaturated fatty acids (LC-PUFA) and
well known to play important regulatory functions in the
immune, nervous and cardiovascular system (Innis, 2007;
Calder, 2009; Calder and Yaqoob, 2009; Russo, 2009). The
n-6 LC-PUFA can be synthesized from linoleic acid (LA; c18:2 n-6)
and those of the n-3 family from a-linolenic acid (ALA;
c18:3 n-3). Synthesis of EPA and DHA from ALA is achieved
by a sequence of desaturation and chain elongation steps,
controlled by the enzymes D5- (FADS1) and D6 desaturase
(FADS2) and presumably elongase 2 (ELOVL2) and -5 (ELOVL5)
(see Figure 1). DHA can be generated from EPA that requires
an additional chain-shortening step (i.e. b-oxidation) in
the peroxisome (Sprecher, 2000; Igarashi et al., 2007a). The
conversion of n-6 LC-PUFA from LA (resulting in the pro-
duction of ARA) sharing the same enzymes resulting in
enzymatic competition between the biosynthetic pathways
of n-3 and n-6 LC-PUFA.
The requirement of LC-PUFA for brain growth and devel-
opment is of current interest. LC-PUFA, in particular DHA and
ARA, accumulate rapidly during the brain growth spurt, the
most critical stage of brain development that takes place
during the later part of gestation and early postnatal life.
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ARA is essential for normal brain growth, playing a role in
synaptic transmission (Bazan, 2003; Sang and Chen, 2006).
Changes in brain DHA concentrations have been demon-
strated to be positively correlated with cognitive develop-
ment (Innis, 2007). In addition, the dietary supplementation
of DHA could improve the cognitive dysfunction due to aging
(McCann and Ames, 2005; Cole and Frautschy, 2006). The
regulatory mechanisms of the conversion of LC-PUFA into
ARA, EPA and DHA, and the consequences of LA- and
ALA-rich diets consumed during childhood remain to be
elucidated. In adult humans, it has been estimated that the
b-oxidation of ALA is 6 20% to 30%, which is much lower
than that of LA, which was estimated to be 12% to 19%
(DeLany et al., 2000). The oxidative losses may partly explain
why the conversion of ALA to EPA and DHA in adults is
low (Burdge and Calder, 2005). In addition, human food
sources such as cereals, sunflower and soybean oil are rich
in LA (.50% of the fat) and have been dominant in the
Western diet over the last decades. Consumption of LA-rich
diets could also result in inadequate conversion of ALA
to DHA and reduced concentrations of DHA in the develop-
ing brain (Russo, 2009). Dietary studies about the effect of
LA are mostly carried out at an isocaloric basis. LA is
then replaced by other energy sources such as oleic acid
(18:1 n-9). However, it has been reported recently that
oleic acid itself can reduce D6-desaturase activity (Portolesi
et al., 2008).
This study focuses on the interactions between the n-3
and n-6 LC-PUFA biosynthetic pathways in liver and brain
using young, growing pigs as a model for human infancy.
This animal model has three major advantages over rodents
when studying lipid metabolism. First, brain anatomy and
morphology and the timing of the brain growth spurt in pigs
and humans are similar (Pond et al., 2000; Duhaime, 2006).
Second, the anatomy of the digestion system, including liver,
stomach and intestine, and also many of the pathways of
lipid metabolism in pigs are rather similar to human
(Moughan et al., 1991; Innis, 1993). Third, the risk for obe-
sity in young, growing pigs is low, enabling large study
contrasts in absolute intakes of LC-PUFA precursors, rather
than exchanging for other nutrients to maintain isocaloric
intake. Here, we have fed young, growing pigs either low or
high amounts of LA and ALA, with equal difference between
low and high in the intake within the respective fatty acid,
and investigated the effect on the fatty acid composition in
liver and brain. In the same tissues, we have determined the
mRNA levels of D6- and D5 desaturase and ELOVL2 and
ELOVL5 by quantitative PCR.
Material and methods
Animals and housing
In all, 32 female pigs were selected from eight litters. From
each litter, four gilts were allotted to one of the four dietary
treatments. On arrival, pigs had a body weight (BW) of 16 kg
(s.d.5 1.8). The pigs were housed individually during an
experimental period of 4 weeks. They were weekly weighed
and feed intake was recorded daily. The experimental pro-
tocol was approved by the Animal Experimental Committee
of Wageningen University, The Netherlands.
Diets
This study was carried out as a 23 2 factorial design with
daily intakes of LA and ALA as independent variables. Differ-
ences between low and high intakes were designed to be
identical for LA and ALA: low ALA and LA intakes were 0.16
and 1.32, and high ALA and LA intakes were 1.48 and 2.65
g/kg BW0.75 per day, respectively. The dietary energy percentage
from LA was 3.4, 3.3, 6.6 and 6.4 and those of ALA was 0.4,
3.7, 0.4 and 3.5 for the diets low LA/low ALA, low LA/high
ALA, high LA/low ALA and high LA/high ALA, respectively. The
size of the experimental contrasts was, in part, based on
recent studies with humans showing an effect of dietary LA on
EPA in plasma phospholipids (Goyens et al., 2006). In addi-
tion, the low LA and ALA intakes were slightly above minimal
requirement figures for pigs (National Research Council, 1998;
Schellingerhout, 2002). The addition of LA and ALA was on
top of a basal diet. The intakes of fatty acids are presented in
Table 1. With the exception of LA and ALA, the intakes of SFA
(saturated fatty acids) and MUFA (monounsaturated fatty
acids) were kept constant. This was done by optimizing the
dosages of analyzed sunflower oil, linseed oil, high-oleic acid
n-6 PUFA n-3 PUFA
c18:2 n-6 (LA) c18:3 n-3 (ALA)
Desaturation
(Δ6 Desaturase)
c18:3 n-6 c18:4 n-3
Elongation
(Elongase 5)
c20:3 n-6 c20:4 n-3
Desaturation
(Δ5 Desaturase)
c20:4 n-6 (ARA) c20:5 n-3 (EPA)
Elongation
(Elongase 2 & 5)
c22:4 n-6 (DTA) c22:5 n-3 (DPA n-3)
Elongation
(Elongase 2)
c24:4 n-6 c24:5 n-3
Desaturation
(Δ6 Desaturase)
c24:5 n-6 c24:6 n-3
-Oxidation
(Acyl-CoA oxidase)
c22:5 n-6 (DPA n-6) c22:6 n-3 (DHA)
Figure 1 General metabolic pathway of n-6 and n-3 fatty acids (adapted
from Igarashi et al., 2007a); LA5 linoleic acid; ALA5a-linolenic acid;
ARA5 arachidonic acid; EPA5 eicosapentaenoic acid; DTA5 docosate-
tranoic acid; DPA5 docosapentaenoic acid; DHA5 docosahexaenoic acid.
Effects of LA and ALA on the conversion of LC PUFA
263
sunflower oil and palm oil. The diets did not contain n-3 or n-6
LC-PUFA other than LA and ALA. The composition of the basal
diet and the inclusion rates of the oils in the treatments are
presented in Table 2. The low LA/low ALA diet was formulated
to contain sufficient ileal digestible amino acids in relation to
energy (CVB Table Pigs, 2007).
As the LA and ALA increments were not exchanged for
other nutrients but dosed on top of the basal diet, digestible
energy intake varied among experimental treatments between
2.6 and 2.83maintenance energy requirement. The diets
were fed twice daily as mash. To allow pigs to express at least
some natural foraging behavior, straw (20 g/day) was provided
daily, which has been demonstrated to alleviate the stress of
individual housing (De Jong et al., 1998; Chaloupkova´ et al.,
2007). Water was provided ad libitum.
Sampling and fatty acid analysis
At the start of the experimental period, blood sample was
taken from each pig at 2.5 h after feeding. At the end of
the experimental period, pigs were anesthetized 2.5 h after
feeding with an administration of ketamine (10 mg/kg BW)
and xylazine (1 mg/kg BW). Blood sample was collected using
cardiac puncture before euthanasia was performed by an
intracardiac administration of pentobarbital (100 mg/kg BW).
Brain and liver were immediately removed after euthanasia.
The total brain, frontal cortex and hippocampus were weighed.
For gene expression measurements, samples (,1 mg) of liver
and hippocampus were rapidly frozen in liquid nitrogen and
stored at 2808C until analysis. Other parts of the collected
tissues were stored at2208C pending fatty acid analysis. Total
lipids were extracted from diets, liver, frontal cortex and
hippocampus with a choloroform : methanol (2 : 1, v/v) Folch
mixture and then saponified and methylated to determine fatty
acid composition by gas chromatography as described pre-
viously (Smink et al., 2008).
Quantitative PCR
Total RNA was isolated from the hippocampus and liver
tissue using TRIzol reagent (Invitrogen, Bleiswijk, The
Netherlands). Reverse transcription of 1mg of total RNA was
performed in a 20-ml reaction using Superscript III reverse
transcriptase (Invitrogen), dNTPs (Roche) and random hex-
amer primers (Roche, Almere, The Netherlands) for 1 h at
508C according to the manufacturer’s protocol (Invitrogen).
Real-time PCR was performed on a LightCycler 2.0 Real-Time
PCR System by using FastStart DNA Master SYBR Green I
reagents (Roche). The primers used are presented in Table 3.
All primer pairs, except for 18S RNA, were designed in such a
way that they span an intron of their corresponding genomic
sequence or that its sense or reverse primer anneals on
an exon-intron junction. Templates were amplified after a
preincubation for 10 min at 958C, followed by amplification for
40 cycles (10 s at 958C, 5 s at 608C, 5 s at 728C). PCR effi-
ciencies for the genes were established to be between 97%
and 100%. Expression levels of FADS1, FADS2, ELOVL2 and
ELOVL5 were normalized using the corresponding values of
18S RNA. All reactions revealed a single product as determined
using melting curve analysis and specificity of the primer sets
were verified by sequencing of the generated amplicons.
Statistical analysis
The trial was conducted as a 23 2 factorial arrangement of
treatments with eight replicates per treatment. The individually
Table 1 Experimental design: average intakes of DE, starch, ileal
digestible lysine, fat and fatty acids1 in g/kg BW0.75 per day
Low LA High LA
Low ALA High ALA Low ALA High ALA
c18:2 n-6 (LA) 1.32 1.31 2.64 2.67
c18:3 n-3 (ALA) 0.15 1.49 0.16 1.47
c12:0 0.03 0.03 0.03 0.03
c14:0 0.02 0.02 0.02 0.02
c16:0 0.69 0.66 0.64 0.60
c16:1 0.01 0.01 0.01 0.01
c18:0 0.13 0.17 0.17 0.22
c18:1 n-9 1.34 1.32 1.31 1.31
c18:1 n-7 0.03 0.04 0.04 0.05
c20:0 0.01 0.01 0.02 0.02
c20:1 n-9 0.01 0.01 0.01 0.01
c22:0 0.02 0.01 0.03 0.03
c24:0 0.01 0.01 0.01 0.01
SFA 0.90 0.91 0.92 0.92
MUFA 1.39 1.38 1.37 1.38
Total fat 4.00 5.42 5.42 6.85
DE (MJ/kg BW0.75 per day)2 1.24 1.30 1.30 1.35
Ileal digestible lysine2 0.89 0.89 0.89 0.89
Starch2 34.7 34.7 34.7 34.7
DE5digestible energy; LA5 linoleic acid; ALA5a-linolenic acid; SFA5 saturated
fatty acid; MUFA5monounsaturated fatty acid.
1Based on analyzed values.
2Based on calculated values (CVB Table Pigs, 2007).
Table 2 Dietary ingredients (in g/kg, relative to the low LA/low ALA
diet) of the dietary treatments with differences in LA and ALA intakes
Low LA High LA
Low ALA High ALA Low ALA High ALA
Basal diet1 967.4 967.4 967.4 967.4
Sunflower oil 10.5 3.36 40.5 33.6
Linseed oil 1.92 34.1 1.85 34.2
HOSF oil 10.3 6.61 3.76 –
Palm oil 9.89 6.07 4.05 –
Total2 1000 1018 1018 1035
LA5 linoleic acid; ALA5a-linolenic acid; HOSF5 high-oleic sunflower oil.
1The basal diet contained (g/kg, as fed) corn starch, 160.1; wheat, 160.5;
barley, 321.0; wheat bran, 53.5; molasses, 32.1; soybean meal, 64.2; peas,
53.5; potato protein, 53.5; wheat gluten, 53.5; limestone, 14.1; monocalcium
phosphate, 13.7; salt, 5,4; vitamin-mineral mix, 10.7; L-lysine HCl 3.0;
L-Threonine, 0.32; tryptophan, 0.32; DL-methionine, 0.54.
2The sum of feed ingredients adds up to 1000 g/kg for the low LA/low ALA
diet only. A total exceeding 1000 reflects an increased feed intake of the
respective treatment group as explained in the text.
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housed pig served as the experimental unit. The results
were analyzed by ANOVA using the software program SAS
version 9.1 (Statistical Analysis Systems Institute Inc., Cary, NC,
USA). The fatty acid concentrations in all tissues and enzyme
RNA concentrations were tested using the following model:
Y ¼mþ LAi þALAj þðLA x ALAÞij þ litterk þ eijk;
where LA5 daily LA intake i (i5 low or high); ALA5
daily ALA intake j (j5 low or high); litter k (k5 1,y, 8).
For fatty acid concentrations in blood plasma, the initial
concentrations, measured at the start of the experiment
were included as a covariate.
Homogeneity of variance was tested using the Shapiro–
Wilk test. When model residuals were not distributed nor-
mally (P, 0.05), the statistical analysis was performed on
transformed data. The level of statistical difference was
preset at P, 0.05.
Results
All pigs remained healthy throughout the study and rates of
BW gain were within the normal range. The effects of LA
and ALA intakes on BW and brain weight are presented in
Table 4. The average BW at slaughter was 29 kg and did not
significantly differ among treatments. Fresh brain weights
(g/kg BW) were significantly (P5 0.012) lower for the pigs
fed the high LA diet. The hippocampus weight was lower
(P5 0.046) for the high ALA groups.
The effects of LA and ALA intakes on the content of liver
fatty acids are presented in Table 5. The results of the dietary
treatments on the composition of plasma fatty acids largely
resembled the effects on liver fatty acid composition (data
not shown). Nearly all fatty acid contents were affected
by LA and ALA intakes. High LA pigs had a significant
(P, 0.0001) higher content of LA and ARA in liver. The
content of n-3 fatty acids such as ALA, docosapentaenoic
acid (DPA; c22:5 n-3) and DHA were decreased (P, 0.01) in
the high LA pigs. A high ALA intake resulted in an increased
(P, 0.0001) ALA and EPA contents in liver. The proportion
of DHA, however, was decreased (P5 0.01) by high intake of
ALA. High ALA pigs had increased content of LA in the liver
but ARA and docosatetraenic acid (DTA; c22:4 n-6) contents
decreased (P, 0.0001) by approximately 50%.
The fatty acid profiles of the frontal cortex and the hip-
pocampus are presented in Tables 6 and 7, respectively. LA
and ALA were hardly present in both brain tissues. ARA
(9%), c22:4 n-6 (3% to 4%) and DHA (7% to 8%) were the
main PUFA in the two brain tissues. High LA intake tended
(P, 0.1) to increase the ARA content and significantly
(P, 0.05) increased the proportion of c22:4 n-6 in both the
hippocampus and frontal cortex. High LA intake resulted in a
significant (P, 0.001) decrease of DPA and a tendency
(P5 0.09) of a decreased DHA content in the frontal cortex.
Increased ALA intake did not affect the ARA and c22:4 n-6
contents but lowered c22:5 n-6 in the frontal cortex. High
ALA increased DPA, but did not affect DHA contents in the
frontal cortex significantly. High LA intake resulted in a
decreased content of DPA but did not affect that of DHA in
the hippocampus. A high ALA intake significantly decreased
all n-6 LC-PUFA, but increased the LA content in the hippo-
campus. High ALA intake increased the DPA content, but did
not affect other n-3 fatty acids.
The change in mRNA expression levels of desaturase and
elongase enzymes were measured in liver and hippocampus
(Table 8). In liver, both LA and ALA intakes significantly
(P, 0.05) increased the transcript level of ELOVL2. On
the contrary, ELOVL5 mRNA was not significantly increased.
Table 3 Quantitative PCR primers
Gene Forward primer Reverse primer
D5 desaturase CAGGATGCTACGGATCCCTTT GCTGCTCCGGAGACAGTTCT
D6 desaturase CAGCACGATTACGGCCATCT AGTTGGCAGAGGCACCCTTT
ELOVL2 TGACGCTGGTCATCCTGTTC CGGCACGTCCGTATCTTTCT
ELOVL5 CCTCTCGGCTGGCTGTACTT GAGAGGCCCCCTTCTTGTTG
18S RNA GTTCAAAGCAGGCCCGAG CGCCGCCGCATCGCCA
Table 4 BW at the start and at the end of the trial and the effect of LA and ALA intakes on brain weight in growing pigs
Low LA High LA
Pooled s.e.m.
P-values for effect
Low ALA High ALA Low ALA High ALA LA ALA LA3ALA
BW start (kg) 16.3 16.4 16.1 16.4 0.68 0.85 0.75 0.85
BW end (kg) 28.5 28.8 29.3 29.7 0.63 0.20 0.61 0.96
Brain (g/BW end) 2.14 2.13 2.00 1.99 0.051 0.012 0.78 0.97
Frontal cortex (g/BW end) 0.48 0.48 0.46 0.44 0.019 0.13 0.56 0.67
Hippocampus (g/BW end) 0.076 0.073 0.076 0.070 0.002 0.37 0.046 0.63
BW5 body weight; LA5 linoleic acid; ALA5a-linolenic acid.
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Table 5 Effect of LA and ALA intakes on the fatty acid profile (% of total fatty acids) of the liver in growing pigs
Low LA High LA
Pooled s.e.m.
P-values of effects
Fatty acids Low ALA High ALA Low ALA High ALA LA ALA LA3 ALA
c16:0 15.1 11.7 13.0 10.5 0.33 ,0.0001 ,0.0001 0.18
c17:0 1.31 1.17 1.29 1.03 0.040 0.49 0.07 0.55
c18:0 23.5 26.7 24.6 24.0 0.43 0.08 ,0.01 ,0.0001
SFA 40.3 39.6 38.9 35.6 0.40 ,0.0001 ,0.001 ,0.01
c16:1 0.53 0.43 0.38 0.26 0.040 ,0.001 0.013 0.75
c18:1 n-7 1.48 1.26 1.11 1.20 0.043 ,0.001 0.17 ,0.01
c18:1 n-9 13.5 10.8 10.7 9.51 0.31 ,0.01 ,0.001 0.79
MUFA 15.7 12.5 12.2 11.1 0.36 ,0.0001 ,0.0001 ,0.01
c18:2 n-6 (LA) 16.4 16.8 21.2 24.3 0.33 ,0.0001 ,0.0001 ,0.001
c20:3 n-6 0.81 0.77 0.68 0.80 0.047 0.28 0.38 0.10
c20:4 n-6 (ARA) 17.4 8.86 19.3 11.1 0.33 ,0.0001 ,0.0001 0.57
c22:4 n-6 (DTA) 0.73 0.13 1.02 0.19 0.036 ,0.0001 ,0.0001 ,0.01
PUFA n-6 35.4 26.6 42.3 36.4 0.36 ,0.0001 ,0.0001 ,0.001
LC n-6 19.0 9.77 21.0 12.1 0.32 ,0.0001 ,0.0001 0.62
c18:3 n-3 (ALA)1 0.48 5.09 0.44 4.18 0.030 ,0.01 ,0.0001 ,0.05
c20:3 n-3 ND 0.87 ND 0.98 0.066 – – –
c20:5 n-3 (EPA) 0.58 8.13 0.28 5.28 0.155 ,0.0001 ,0.0001 ,0.0001
c22:5 n-3 (DPA n-3) 2.42 3.23 1.67 2.66 0.079 ,0.0001 ,0.0001 0.26
c22:6 n-3 (DHA) 2.63 2.33 2.10 1.71 0.123 0.0001 0.010 0.07
PUFA n-3 6.16 19.7 4.50 14.8 0.25 ,0.0001 ,0.0001 ,0.0001
LC n-3 5.67 14.6 4.06 10.6 0.181 ,0.0001 ,0.0001 ,0.0001
c16:1/c16:0 0.035 0.037 0.029 0.024 0.0028 ,0.01 0.56 0.24
c18:1 n-9/c18:0 0.58 0.40 0.44 0.40 0.019 ,0.001 ,0.001 ,0.01
LA5 linoleic acid; ALA5a-linolenic acid; SFA5 saturated fatty acids; MUFA5monounsaturated fatty acids; ARA5 arachidonic acid; DTA5docosatetraenic acid;
PUFA5polyunsaturated fatty acids; LC5 long chain (fatty acids with 20 or 22 C-atoms); EPA5eicosapentaenoic acid; DPA5docosapentaenoic acid; DHA5docosahexaenoic
acid.
1P-value and s.e.m. are obtained from Y5 log(11x) function.
Table 6 Effect of LA and ALA intakes on the fatty acid profile (% of total fatty acids) of the frontal cortex in growing pigs
Low LA High LA
Pooled s.e.m.
P-values of effects
Fatty acids Low ALA High ALA Low ALA High ALA LA ALA LA3 ALA
c16:0 20.0 19.4 19.2 19.3 0.234 0.06 0.30 0.20
c18:0 18.2 17.9 17.8 17.8 0.184 0.24 0.58 0.32
SFA 39.4 38.5 38.2 38.3 0.406 0.13 0.33 0.25
c16:1 0.89 0.94 0.90 0.92 0.018 0.76 0.07 0.26
c17:1 1.48 1.60 1.72 1.59 0.099 0.27 0.93 0.23
c18:1 n-7 4.91 4.93 5.03 5.02 0.097 0.30 0.97 0.23
c18:1 n-9 16.8 17.4 17.7 17.1 0.482 0.56 0.96 0.18
MUFA 24.9 25.8 26.3 25.4 0.733 0.48 0.97 0.89
c18:2 n-6 (LA) 0.69 0.80 0.79 0.90 0.030 ,0.01 ,0.01 0.91
c20:4 n-6 (ARA) 8.85 8.40 8.92 9.28 0.237 0.06 0.85 0.10
c22:4 n-6 (DTA) 3.30 3.04 3.39 3.36 0.086 0.027 0.10 0.21
c22:5 n-6 (DPA n-6) 1.18 0.59 1.02 0.61 0.094 0.46 ,0.0001 0.34
PUFA n-6 14.5 13.4 14.6 14.7 0.330 0.015 0.17 0.08
LC n-6 13.8 12.6 13.8 13.8 0.330 0.07 0.09 0.08
c18:3 n-3 (ALA) 0.62 0.68 0.72 0.63 0.066 0.70 0.72 0.10
c22:5 n-3 (DPA n-3) 0.24 0.56 0.21 0.46 0.015 ,0.001 ,0.0001 ,0.05
c22:6 n-3 (DHA) 7.77 8.14 6.81 7.69 0.393 0.09 0.13 0.52
PUFA n-3 8.56 9.39 7.68 8.74 0.356 0.044 0.015 0.74
LC n-3 8.16 8.91 7.20 8.30 0.388 0.06 0.027 0.65
LA5 linoleic acid; ALA5a-linolenic acid; SFA5 saturated fatty acids; MUFA5monounsaturated fatty acids; ARA5 arachidonic acid; DTA5 docosatetraenic acid;
DPA5 docosapentaenoic acid; PUFA5 polyunsaturated fatty acids; LC5 long chain (fatty acids with 20 or 22 C-atoms); DHA5 docosahexaenoic acid.
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In addition, both hepatic transcript levels of D5- and
D6 desaturase were increased following high LA intake
(P, 0.01). In hippocampus, high ALA intake significantly
(P5 0.022) increased the mRNA expression of ELOVL2, but
not of ELOVL5, D6- and D5 desaturase. In contrast, variation
in LA intake had no effect on the mRNA expression of these
four genes.
Discussion
The formulated diets contained LA and ALA and were free
of other n-3 or n-6 LC-PUFA. Once consumed, LA and ALA
can be converted to other LC-PUFA by desaturation and
elongation. The route and assumed enzymes involved in the
biosynthesis of LC-PUFA are given in Figure 1.
Table 7 Effect of LA and ALA intakes on the fatty acid profile (% of total fatty acids) of the hippocampus in growing pigs
Low LA High LA
Pooled s.e.m.
P-values of effects
Fatty acids Low ALA High ALA Low ALA High ALA LA ALA LA3ALA
c14:0 0.46 0.44 0.45 0.43 0.0059 0.13 ,0.05 0.90
c16:0 17.6 17.5 18.3 17.8 0.36 0.17 0.47 0.61
c17:0 0.21 0.21 0.21 0.20 0.0040 0.35 0.12 0.17
c18:0 18.5 18.4 18.6 18.6 0.14 0.42 0.60 0.73
SFA1 37.6 37.2 38.4 37.7 0.47 0.20 0.27 0.80
c16:1 0.83 0.86 0.80 0.52 0.011 ,0.01 0.015 0.50
c17:1 1.15 1.28 1.06 1.17 0.073 0.17 0.12 0.91
c18:1 n-7 4.93 4.80 4.72 4.80 0.047 0.031 0.57 0.041
c18:1 n-9 18.5 19.0 17.6 18.3 0.54 0.15 0.29 0.80
c20:1 n-9 0.74 0.76 0.62 0.68 0.050 0.07 0.45 0.63
MUFA 26.5 27.0 25.0 26.0 0.72 0.12 0.31 0.74
c18:2 n-6 (LA) 0.53 0.70 0.56 0.94 0.10 0.19 0.010 0.29
c20:4 n-6 (ARA) 8.90 8.33 9.35 8.81 0.24 0.07 0.033 0.96
c22:4 n-6 (DTA) 4.18 3.87 4.42 4.12 0.098 0.018 ,0.01 0.96
c22:5 n-6 (DPA n-6) 0.70 0.43 0.88 0.50 0.034 0.03 ,0.0001 0.14
PUFA n-6 14.1 13.5 14.8 14.5 0.37 0.02 0.06 0.81
LC n-6 13.6 12.8 14.2 13.5 0.32 0.03 0.01 0.97
c18:3 n-3 (ALA)1 0.45 0.48 0.38 0.43 0.194 0.56 0.29 0.06
c20:3 n-3 0.04 0.04 0.03 0.06 0.027 0.86 0.59 0.82
c20:5 n-3 (EPA) 0.07 0.06 0.06 0.06 0.0051 0.13 0.25 0.67
c22:5 n-3 (DPA n-3) 0.29 0.67 0.26 0.54 0.011 ,0.0001 ,0.0001 ,0.001
c22:6 n-3 (DHA) 6.38 6.65 6.96 6.93 0.31 0.18 0.71 0.63
PUFA n-3 7.23 7.90 7.69 8.02 0.29 0.32 0.10 0.55
LC n-3 6.78 7.42 7.31 7.58 0.31 0.29 0.17 0.56
LA5 linoleic acid; ALA5a-linolenic acid; MUFA5monounsaturated fatty acids; ARA5 arachidonic acid; DTA5 docosatetraenic acid; DPA5 docosapentaenoic
acid; PUFA5 polyunsaturated fatty acids; LC5 long chain (fatty acids with 20 or 22 C-atoms); EPA5 eicosapentaenoic acid; DHA5 docosahexaenoic acid.
1P-value and s.e.m. are obtained from an inverse function.
Table 8 Effects of LA and ALA intakes on the mRNAs of D5- and D6 desaturases and elongase 2 and -5 in liver and hippocampus of growing pigs
Low LA High LA
Pooled s.e.m.
P-values for effect
Low ALA High ALA Low ALA High ALA LA ALA LA3ALA
Liver
ELOVL2 1.00 2.44 2.40 3.53 0.412 0.044 0.037 0.24
ELOVL5 1.00 1.13 1.20 1.24 0.108 0.11 0.27 0.92
D5 desaturase 1.00 1.08 1.60 1.78 0.219 ,0.01 0.57 0.81
D6 desaturase 1.00 1.15 1.54 1.71 0.158 ,0.01 0.33 0.96
Hippocampus
ELOVL2 1.00 2.81 1.80 2.14 0.421 0.89 0.022 0.09
ELOVL5 1.00 1.59 1.02 1.22 0.248 0.50 0.13 0.43
D5 desaturase 1.00 1.60 1.14 1.05 0.393 0.58 0.51 0.36
D6 desaturase 1.00 1.73 1.00 1.14 0.264 0.27 0.12 0.27
LA5 linoleic acid; ALA5a-linolenic acid.
mRNA levels were quantified by quantitative PCR and normalized to 18S ribosomal RNA. They are expressed relative to the Low LA/Low ALA diet group (1.00).
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In this study, we supplied LA or ALA maintaining identical
intakes of other nutrients, an approach that allows inde-
pendent evaluation of the effects of LA and ALA in liver and
brain. Importantly, we did not observe a difference in BW of
the gilts among the experimental groups.
Liver
A high LA intake increased the content of LA and n-6 LC-PUFA
such as ARA in liver lipid. This agrees well with other studies in
pigs (Romans et al., 1995; Schellingerhout, 2002). Increasing
the ALA intake by 1.3 g/kg BW0.75 per day increased the EPA
content in liver lipid from less than 1% to 8%. In contrast to
other n-3 LC-PUFA, the DHA content was decreased by high
ALA intake. Interestingly, a similar effect was seen on the
content of ALA, EPA and DHA in plasma phospholipids in
humans (Goyens et al., 2006), indicating that the composition
of these plasma lipids is a reflection of the lipid metabolism of
the liver. Other earlier studies showed that plasma DHA level
was not affected or marginally increased in humans by dietary
ALA (Blank et al., 2002; Burdge and Calder, 2005). In contrast
to our study, these authors compensated the higher intake
of ALA with a decrease in the intake of other fatty acids.
We believe that caution should be taken in choosing this
exchange approach, as there is evidence that other lipids such
as LA, oleic acid and myristic acid (c14:0) can alter hepatic
desaturase activity as well (Be´zard et al., 1994; Jan et al.,
2004; Portolesi et al., 2008; Rioux et al., 2008). These fatty
acids may contribute to the observed opposite effects on
plasma DHA in their studies.
This study shows that high LA intake increased levels of
both D5- and D6-desaturase mRNA in liver. Similar effects
have been found in rats (Be´zard et al., 1994) and piglets (Theil
and Lauridsen, 2007). In contrast, in a human hepatoma cell
line a suppression of D6-desaturase mRNA content was seen
after the addition of LA or ALA (Portolesi et al., 2008).
Increased ALA intake had no effect onD5- andD6 desaturase.
The rate-limiting enzyme D6 desaturase has been reported to
have a higher affinity for ALA than for LA (Rodriguez et al.,
1998; Sprecher, 2002). Although not measured in our model, it
is tempting to speculate that the surfeit of ALA in liver is
preferentially converted above LA down the cascade (Figure 1)
or alternatively catabolized (via b-oxidation) and that the
LA-elevated expression of D6 (and D5)-desaturase may be
necessary to metabolize the surplus of LA provided by the
diet. Indeed, we found a strong increase in the EPA content in
liver lipid in response to ALA intake, suggesting that the
enzymatic activity of both desaturases and ELOVL5, at least
for ALA, were not rate limiting.
In our study, high LA and high ALA intakes increased the
transcript of ELOVL2 but not of ELOVL5 in the liver of
growing piglets. These findings indicate that the conversion
of ARA and EPA to longer elongation products became more
efficient (see Figure 1). Indeed, we found an increased pro-
portion of DPA and DTA in liver lipid in response to ALA and
LA intakes, respectively. Unfortunately, we did not have the
standards in order to establish whether this was paralleled
by a positive effect on the content of c24:5 n-3 and c24:4 n-6
as well. Fatty acid-dependent changes in hepatic ELOVL2
expression have also been reported in rat and salmon
(Igarashi et al., 2007a; Morais et al., 2009).
Interestingly, DHA levels were significantly reduced,
whereas ELOVL2 mRNA expression was increased in response
to ALA intake. This finding suggests a rate-limiting enzyme
downstream of ELOVL2. As D6 desaturase has a higher
affinity for ALA than for c24:5 n-3 (D’Andrea et al., 2002;
Portolesi et al., 2007), it is conceivable thatD6 desaturation of
c24:5 n-3 is inhibited when ALA is abundant, preventing DHA
synthesis. We would suggest that in the liver of piglets, D6
desaturase rather than ELOVL2 is the rate-limiting enzyme
downstream of EPA in the biosynthesis of DHA. Whether ALA
has any inhibitory effect on the peroxisomal b-oxidation of
c24:6 n-3 remains to be elucidated.
Increased intake of LA decreased the proportion of total
n-3 LC-PUFA and a high intake of ALA decreased the total
n-6 LC-PUFA in liver lipid. This confirms the general concept
that competition between ALA and LA occurs because of
sharing of the same desaturation and elongation enzymes. In
addition, this study illustrates that for EPA and DHA, the
effects of LA intake are stronger at high ALA intake and the
effects of ALA intake are stronger at low LA intake (inter-
action LA3ALA for EPA, DHA, P, 0.001 and P5 0.07,
respectively). The first concern is the effect of high LA as the
Western diet is generally rich in LA and poor in n-3 fatty
acids. High LA intake in our study decreased the proportion
of EPA and DHA in liver fat by .35% and .20%, respec-
tively. A similar effect was also observed in blood plasma fat.
On the other hand, high ALA intake drastically decreased the
proportion of ARA by approximately 50%. This inhibitory
effect provides a strong indication that ALA and LA com-
petes for the same desaturases and elongases.
Taken together, our experimental design allows a direct
comparison of the effects of identical increments in daily
intakes of LA and ALA (both 1.3 g/kg BW0.75), which is rarely
found in literature. The effect of LA both as a substrate of the
n-6 chain and as an inhibitor of the n-3 chain was much
lower in comparison with that of ALA. Generally, the effect
of ALA on LC PUFA appeared to be four times stronger than
that of LA. Our findings in growing piglets are in agreement
with human intervention studies showing a strong positive
correlation of ALA intake and blood EPA, but weaker
between LA intake and blood ARA (Mantzioris et al., 1995).
Brain
The timing of the pig brain growth spurt is similar to that in
humans (Dobbing and Sands, 1979; Pond et al., 2000).
Several trials with young piglets were conducted to study the
effect of dietary fat on brain fatty acid composition (Arbuckle
et al., 1991; De la Presa-Owens et al., 1998; Arbuckle and
Innis, 2003). These nutritional intervention studies were
mainly focused on whole brain. In this study, we selected the
frontal cortex, representing a rather large region of the brain,
with primary functions (Ng and Innis, 2003), and in addition,
the hippocampus, which is involved in the memory storage
and retrieval. Although it has been reported that deprivation
Smink, Gerrits, Gloaguen, Ruiter and van Baal
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of essential fatty acids causes a decrease in brain weight
(Odutuga, 1981), we found to our surprise a decreased brain
weight in response to increased LA intake, irrespective of
ALA intake. This is in contrast with the study by Hrboticky
et al. (1990), showing that higher LA at the expense of oleic
acid did not affect brain weight in young piglets. In our study,
an increased LA intake tended (P, 0.1) to increase ARA and
significantly increased c22:4 n-6 in fat extracts of both hip-
pocampus and frontal cortex. Moreover, high ALA intake
increased DPA, but not DHA concentrations in the fat of
those brain tissues. Earlier studies in piglets demonstrated
an increase in brain DHA by dietary ALA (Arbuckle et al,
1991). The difference in the effect on DHA between the latter
and our study may be due to their use of younger piglets,
knowing that younger piglets respond stronger to dietary
PUFA (Cheon et al., 2000). However, the lack of the effect on
brain DHA was also found in adult rats in which ALA intake
exceeded the low ALA groups in our study (Bourre et al.,
1993). The elongation of n-3 fatty acids in brain astrocytes
did not extend beyond DPA (Innis and Dyer, 2002). Although
high ALA intake drastically increased the ALA content in
plasma lipids (an increase of the proportion from 6 1% to
10%), which is a reflection of the increase of ALA content in
liver (Table 4), the ALA and DHA contents in frontal cortex
and hippocampus did not increase (Tables 5 and 6). Other
studies in rat brain showed that ALA after uptake from the
circulation across the blood-brain barrier will be mainly
oxidized and only a small fraction is converted to DHA
(DeMar et al., 2005; Igarashi et al., 2007b). The activity of
desaturation and elongation are higher in liver in comparison
with brain (Igarashi et al., 2007a). This suggests that most
DHA in the brain is derived from another source, such as
liver, intestine (diet) and/or adipose tissue. Surprisingly,
the DHA concentration in the pig liver lipid decreased
with increasing ALA intake. High ALA intake resulted in a
significant increase in ELOVL2 mRNA expression, which
may relate to the strong increase in the content of DPA, a
product of ELOVL2, in both frontal cortex and hippocampus.
On the other hand, we did not observe an effect on mRNA
expression of D6 and D5 desaturase and ELOVL5 in the
hippocampus that agrees with studies in rat brain (Igarashi
et al., 2007a).
Similarly to liver, high dietary ALA intake increased the
concentration of LA in fat extracts of both frontal cortex and
hippocampus. The proportion of ALA, however, was not
increased. The latter may be due to a high rate of oxidation
in brain (DeMar et al., 2005), or elongation and desatura-
tion, resulting in increased concentrations of n-3 LC PUFA in
the frontal cortex. The higher LA concentration in high ALA
diets might be due to competition for enzymes and sparing
of LA oxidation in the presence of ALA. The rate of oxidation
of ALA is higher than that of LA (DeLany et al., 2000).
In conclusion, the effect of LA and ALA are important both
as precursor and inhibitor for the synthesis of LC-PUFA. LA as
a substrate is increasing mRNA expression of D6- and D5
desaturase and all n-6 PUFA in liver. High ALA intake
did increase EPA in liver lipid but decreased the proportion
of DHA. This study supports the idea that high dietary LA
intake inhibits the conversion of ALA into n-3 LC-PUFA and
that ALA inhibits the conversion of LA into n-6 LC-PUFA. The
magnitude of the effect of ALA in liver is higher than that of
LA. This suggests that manipulation of ARA and EPA avail-
ability by dietary interventions should be optimized varying
both dietary LA and ALA. DHA in brain tissue is hardly
affected by both dietary LA and ALA. mRNA expression of
ELOVL2 was upregulated by dietary treatment and was,
apart from D6 desaturase, identified as a potentially rate-
limiting step.
Acknowledgements
This study was funded by the Dutch Ministry of Agriculture,
Nature and Food quality. We thank Ronald P. Mensink for critical
comments and Tamme Zandstra, Wouter Rijm, Robert Hovenier,
Adriana Silveira de Souza, Marleen Scheer, Ilse van Kerkhof and
people of ‘The Haar’ for their technical assistance.
References
Arbuckle LD and Innis SM 2003. Docosahexaenoic acid in developing brain
and retina of piglets fed high or low alpha-linolenate formula with and without
fish oil. Lipids 27, 89–93.
Arbuckle LD, Rioux FM, Mackinnon MJ, Hrboticky N and Innis SM 1991.
Response of (n-3) and (n-6) fatty acids in piglet brain, liver and plasma to
increasing, but low, fish oil supplementation of formula. Journal of Nutrition
121, 1536–1547.
Bazan NG 2003. Synaptic lipid signaling: significance of polyunsaturated fatty
acids and platelet-activating factor. Journal of Lipid Research 44, 222–233.
Be´zard J, Blond JP, Bernard A and Clouet P 1994. The metabolism and
availability of essential fatty acids in animal and human tissues. Reproduction
Nutrition Development 34, 539–568.
Blank C, Neumann MA, Makrides M and Gibson RA 2002. Optimizing DHA
levels in piglets by lowering the linoleic acid to a-linolenic acid ratio. Journal of
Lipid Research 43, 1537–1543.
Bourre JM, Dumont O, Pascal G and Durand G 1993. Dietary a-linolenic acid at
1.3 g/kg maintains maximal docosahexaenoic acid concentration in brain, heart
and liver of adult rats. Journal of Nutrition 123, 1313–1319.
Burdge GC and Calder PC 2005. a-Linolenic acid metabolism in adult humans:
the effects of gender and age on conversion to longer-chain polyunsaturated
fatty acids. European Journal of Lipid Science and Technology 107, 426–439.
Calder PC 2009. The relationship between the fatty acid composition of immune
cells and their function. Prostaglandins, Leukotrienes and Essential Fatty Acids
79, 101–108.
Calder PC and Yaqoob P 2009. Omega-3 polyunsaturated fatty acids and human
health outcomes. Biofactors 35, 266–272.
Chaloupkova´ H, Illmann G, Neuhauserova´ K, Toma´nek M and Valis L 2007.
Preweaning housing effects on behavior and physiological measures in pigs
during the suckling and fattening periods. Journal of Animal Science 85,
1741–1749.
Cheon SH, Huh MH, Lee YB, Park JS, Sohn HS and Chung CH 2000. Effect of
dietary linoleate/alpha-linolenate balance on the brain lipid composition,
reproductive outcome and behavior of rats during their prenatal and postnatal
development. Bioscience, Biotechnology and Biochemistry 64, 2290–2297.
Cole GM and Frautschy SA 2006. Docosahexaenoic acid protects from amyloid
and dendritic pathology in an Alzheimer’s disease mouse model. Nutrition and
Health 18, 249–259.
CVB Table Pigs 2007. Chemical composition and nutritional value of feedstuffs
and feeding standards. CVB series no 36, The Hague, The Netherlands.
D’Andrea S, Guillou H, Jan S, Catheline D, Thibault JN, Bouriel M, Rioux V and
Legrand P 2002. The same rat delta 6-desaturase not only acts on 18- but also
on 24-carbon fatty acids in very-long-chain polyunsaturated fatty acid
biosynthesis. Biochemical Journal 364, 49–55.
Effects of LA and ALA on the conversion of LC PUFA
269
De Jong IC, Ekkel ED, van de Burgwal JA, Lambooij E, Korte SM, Ruis MA,
Koolhaas JM and Blokhuis HJ 1998. Effects of strawbedding on physiological
responses to stressors and behavior in growing pigs. Physiological Behaviour
64, 303–310.
DeLany JP, Windhauser MM, Champagne CM and Bray GA 2000. Differential
oxidation of individual dietary fatty acids in humans. American Journal of
Clinical Nutrition 72, 905–911.
De la Presa-Owens S, Innis SH and Rioux FM 1998. Addition of triglycerides with
arachidonic acid or docosahexaenoic acid to infant formula has tissue- and lipid
class-specific effects on fatty acids and hepatic desaturase activities in formula
fed piglets. Journal of Nutrition 128, 1376–1384.
DeMar JC Jr, Ma K, Chang L, Bell JM and Rapoport SI 2005. a-Linolenic acid
does not contribute appreciably to docosahexaenoic acid within brain
phospholipids of adult rats fed a diet enriched in docosahexaenoic acid. Journal
of Neurochemistry 94, 1063–1076.
Dobbing J and Sands J 1979. Comparative aspects of the brain growth spurt.
Early Human Development 311, 79–83.
Duhaime AC 2006. Large animal models of traumatic injury to the immature
brain. Developmental Neuroscience 28, 380–387.
Goyens PLL, Spilker ME, Zock PL, Katan MB and Mensink RP 2006. Conversion
of a-linolenic acid in humans is influenced by the absolute amounts of
a-linolenic acid and linoleic in the diet and not by their ratio. American Journal
of Clinical Nutrition 84, 44–53.
Hrboticky N, MacKinnon MJ and Innis SM 1990. Effect of a vegetable oil formula
rich in linoleic acid on tissue fatty acid accretion in the brain, liver, plasma, and
erythrocytes of infant piglets. American Journal of Clinical Nutrition 51, 173–182.
Igarashi M, Ma K, Chang L, Bell JM and Rapoport SI 2007a. Dietary n-3 PUFA
deprivation for 15 weeks upregulates elongase and desaturase expression in rat
liver but not brain. Journal of Lipid Research 48, 2463–2470.
Igarashi M, DeMar JC, Ma K, Chang L, Bell JM and Rapoport SL 2007b.
Docosahexaenoic acid synthesis from a-linolenic acid by rat brain is unaffected
by dietary n-3 deprivation. Journal of Lipid Research 48, 1150–1158.
Innis SM 1993. The colostrum deprived piglet as a model for study of infant lipid
nutrition. Journal of Nutrition 123, 386–390.
Innis SM 2007. Dietary (n-3) fatty acids and brain development. Journal of
Nutrition 137, 855–859.
Innis SM and Dyer RA 2002. Brain astrocyte synthesis of docosahexaenoic acid
from n-3 fatty acids is limited at the elongation of docosapentaenoic acid.
Journal of Lipid Research 43, 1529–1536.
Jan S, Guillou H, D’Andrea S, Daval S, Bouriel M, Rioux V and Legrand P 2004.
Myristic acid increases D6-desaturase activity in cultured rat hepatocytes.
Reproduction Nutrition Development 44, 131–140.
Mantzioris E, James MJ, Gibson RA and Cleland LG 1995. Differences exist in the
relationships between dietary linoleic and a-linolenic acids and their respective
long-chain metabolites. American Journal of Clinical Nutrition 61, 320–324.
McCann J and Ames BN 2005. Is docosahexaenoic acid, an n-3 long-chain
polyunsaturated fatty acid, required for development of normal brain function?
An overview of evidence from cognitive and behavioral tests in humans and
animals. American Journal of Clinical Nutrition 82, 281–295.
Morais S, Monroig O, Zheng X, Leaver MJ and Tocher DR 2009. Highly
unsaturated fatty acid synthesis in Atlantic salmon: characterization of ELOVL5-
and ELOVL2-like elongases. Marine Biotechnology (New York) 11, 627–639.
Moughan PJ, Cranwell PD, Darragh AJ and Rowan AM 1991. The domestic pig
as a model for studying digestion in humans. In Digestive Physiology in Pigs –
Proceedings of the Vth International Symposium on Digestive Physiology in Pigs,
24–26 April 1991 (ed. Huisman J, Den Hartog LA and Verstegen MWA), EAAP
Publications no. 80, pp. 389–396. Pudoc, Wageningen, The Netherlands.
National Research Council 1998. Nutrients requirements of swine, 10th edition.
National Academy Press, Washington, DC, USA.
Ng KF and Innis SM 2003. Behavioral responses are altered in piglets with
decreased frontal cortex docosahexaenoic acid. Journal of Nutrition 133,
3222–3227.
Odutuga AA 1981. Reversal of brain essential fatty acid deficiency in the rat by
dietary linoleate, linolenate and arachidonate. International Journal of
Biochemistry 13, 1035–1038.
Pond WG, Boleman SL, Fiorotto ML, Ho H, Knabe DA, Merssmann HJ, Savell JW
and Su DR 2000. Perinatal ontogeny of brain growth in the domestic pig.
Proceedings of the Society for Experimental Biology and Medicine 223,
102–108.
Portolesi R, Powell BC and Gibson RA 2007. Competition between 24:5n-3 and
ALA for D6 desaturase may limit the accumulation of DHA in HepG2 cell
membranes. Journal of Lipid Research 48, 1592–1598.
Portolesi R, Powell BC and Gibson RA 2008.D6 desaturase mRNA abundance in
HepG2 cells is suppressed by unsaturated fatty acids. Lipids 43, 91–95.
Rioux V, Cathelina D, Beauchamp E, Le Bloc’h J, Pedrono F and Legrand P 2008.
Substitution of dietary oleic acid for myristic acid increases the tissue storage of
a-linolenic acid and the concentration of docosahexaenoic acid in the brain, red
blood cells and plasma in the rat. Animal 2, 636–644.
Rodriguez A, Sarda P, Nessmann C, Boulot P, Leger CL and Descomps B 1998.
D6- and D5-desaturase activities in the human fetal liver: kinetic aspects.
Journal of Lipid Research 39, 1825–1832.
Romans JR, Wulf DM, Johnson RC, Libal GW and Costello WJ 1995. Effects of
ground flaxseed in swine diets on pig performance and on physical and sensory
characteristics and omega-3 fatty acid content of pork: II duration of 15%
dietary flaxseed. Journal of Animal Science 73, 1987–1999.
Russo GL 2009. Dietary n-6 and n-3 polyunsaturated fatty acids: from
biochemistry to clinical implications in cardiovascular prevention. Biochemical
Pharmacology 77, 937–946.
Sang N and Chen C 2006. Lipid signalling and synaptic plasticity. Neuroscientist
12, 425–434.
Schellingerhout AB 2002. Essential-fatty acid supply of weaning piglets. PhD,
Utrecht University.
Smink W, Gerrits WJJ, Hovenier R, Geelen MJ, Lobee HW, Verstegen MW and
Beynen AC 2008. Fatty acid digestion and deposition in broiler chickens fed
diets containing either native or randomized palm oil. Poultry Science 87,
506–513.
Sprecher H 2000. Metabolism of highly unsaturated n-3 and n-6 fatty acids.
Biochimica et Biophysica Acta 1486, 219–231.
Sprecher H 2002. The roles of anabolic and catabolic reactions in the synthesis
and recycling of polyunsaturated fatty acids. Prostaglandins Leukotrienes and
Essential Fatty Acids 67, 79–83.
Theil PK and Lauridsen C 2007. Interactions between dietary fatty acids and
hepatic gene expression in livers of pigs during the weaning period. Livestock
Science 108, 26–29.
Smink, Gerrits, Gloaguen, Ruiter and van Baal
270
